Ovarian Cancer
Ovarian cancer prognosis may be associated with ID2 and DCN expression
Published in Women's Health Weekly, September 14th, 2006
"The majority of epithelial ovarian carcinomas are of serous subtype, with most women presenting at an advanced stage. Approximately 70% respond to initial chemotherapy but eventually relapse. We aimed to find markers of treatment response that might be suitable for routine use, using the gene expression profile of tumor tissue," stated investigators writing in the International Journal of Cancer.
T.R. Newton and colleagues of the Queensland Institute of Medical Research explained, "Thirty one women with histologically-confirmed late-stage serous ovarian...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Epithelial cells in nipple aspirate fluid may signify increased breast cancer risk - Breast Cancer
Gene regulation characteristic of tamoxifen may be an advantage over aromatase inhibitors - Cardiology
Atrial fibrillation recurrence after cardioversion is more prevalent in women than men - Obesity & Mortality
Premature death in women may be associated with moderate obesity at age 18 - Obstetrics
Breastfeeding in HIV-positive women may be associated with reduced mortality among offspring - Alcohol Use
Alcohol increases sleep intensity in young women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
